Av. Benjafield et Bj. Morris, Association analyses of endothelial nitric oxide synthase gene polymorphisms in essential hypertension, AM J HYPERT, 13(9), 2000, pp. 994-998
Endothelial nitric oxide synthase (eNOS), encoded by NOS3, is a potent regu
lator of vasomotor tone and peripheral resistance. Congenic experiments ind
icate that a chromosomal segment containing the rat eNOS gene contributes t
o rat spontaneous hypertension (HT). A role for NOS3 in onset of essential
hypertension (HT) is, however, controversial. We therefore decided to test
NOS3 polymorphisms in a set of patients who have an accentuated ability to
show an existing genetic association. The 112 HT subjects had two HT parent
s and the normotensive (NT) subjects had two NT parents. All were Anglo-Cel
tic whites. The two most promising polymorphisms, viz, a biallelic variable
number of tandem repeats (VNTR) in intron 4 and an exon 7 variant that lea
ds to an amino acid change (Glu298Asp), were genotyped by PCR (and BanII di
gestion in the case of the latter). Frequency of the minor allele of the VN
TR was 0.11 in the NT and 0.10 in the HT subjects (P = .9). For the exon 7
variant, Asp298 frequency was 0.30 and 0.32 in each respective group (P = .
6). Tracking was seen for the Asp298 allele with elevation in body mass ind
ex (P = .034), and the minor allele of the VNTR with elevation in LDL (P =
.007) and reduction in HDL (P = .048). In conclusion, we saw no association
of NOS3 markers with HT in the population studied. However, possible genot
ypic effects on plasma lipids and body mass index might warrant further stu
dies, especially in view of possible associations with heart disease. Am J
Hypertens 2000;13:994-998 (C) 2000 American Journal of Hypertension, Ltd.